Voices From mHealth 2015: FDA's Suzanne Schwartz On Cybersecurity
This article was originally published in The Gray Sheet
FDA's medical device emergency preparedness leader spoke to "The Gray Sheet" about the agency's progress in cybersecurity, the need to bake security into device design and the product lifecycle, and the importance of collaboration. "The environment in which device and connected systems are utilized in the hospital is an environment that is basically under attack," Schwartz said in a podcast interview from the 2015 mHealth Summit.
You may also be interested in...
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.